{"id":132029,"date":"2024-08-27T11:21:10","date_gmt":"2024-08-27T05:51:10","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=132029"},"modified":"2024-08-27T11:24:39","modified_gmt":"2024-08-27T05:54:39","slug":"pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/","title":{"rendered":"Pharma stock jumps 5% after company&#8217;s board approved buyback at 50% premium"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1718355261\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Pharma stock engaged in manufacturing and selling APIs, Pharma Intermediates, Specialty Chemicals, and many more jumped 5 percent in the day\u2019s trade following the announcement to Buyback equity shares at a 50 percent premium and fixing record date.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2464001066\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price Action&nbsp;<\/strong><\/h2><p>With a market capitalization of Rs. 5,562 Crores, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/AARTIDRUGS\/standalone\" target=\"_blank\" rel=\"noreferrer noopener\">Aarti Drugs Limited<\/a><\/strong> were trading at Rs. 605 per equity share, down 0.22 percent from its previous day\u2019s close price of Rs. 606.35.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Buyback of Equity shares&nbsp;<\/strong><\/h2><p>The Board of Directors of Aarti Drugs Limited has considered and approved the resolution for the Buyback of upto 6.65 lakh Equity shares representing 0.72 percent holding of the company at Rs. 900 per share which is a premium of ~50 percent from its current price of Rs. 605.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also Read<\/strong><\/p>\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-trade-brains wp-block-embed-trade-brains\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"9FAB1466yD\"><a href=\"https:\/\/tradebrains.in\/features\/4-stocks-that-hit-20-upper-circuit-today-do-you-own-any\/\">4 Stocks that hit 20% upper circuit today; Do you own any?<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;4 Stocks that hit 20% upper circuit today; Do you own any?&#8221; &#8212; Trade Brains\" src=\"https:\/\/tradebrains.in\/features\/4-stocks-that-hit-20-upper-circuit-today-do-you-own-any\/embed\/#?secret=NlJS49AB93#?secret=9FAB1466yD\" data-secret=\"9FAB1466yD\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure><\/blockquote><p>The Buyback is gonna take place through a tender offer route for an aggregate consideration of Rs. 59.85 Crores and September 5, 2024, is fixed as the record date to determine eligible shareholders for the buyback.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-3666007957\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company&nbsp;<\/strong><\/h2><p>Aarti Drugs Limited is engaged in manufacturing and selling Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals as well as Formulations.&nbsp;<\/p><p>It is the largest producer of Nimesulide, Metronidazole Benzoate, Ketoconazole, Tinidazole, Fluoroquinolones group, and Metformin in the world. It has a presence across 100+ countries with 13 manufacturing plants, 80+ finished products, and 50+ API molecules.&nbsp;<\/p><p>It has a strong clientele base with well-known players like Cipla, Sun Pharma, Lupin, Mankind, Sanofi, Zydus, and many others. As of Q1FY25, It generated 80 percent of its revenue from APIs, Formulations 12 percent, Specialty Chemicals 5 percent, and Intermediates &amp; others 3 percent.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials and Ratios&nbsp;<\/strong><\/h2><p>Its revenue from operations declined by 17 percent from Rs. 592 Crores in Q1FY24 to Rs. 493 Crores in Q1FY25, accompanied by profits of Rs. 40 Crores to Rs. 27 Crores.&nbsp;<\/p><p>In terms of Return ratios, it has reported a return on equity (ROE) of 12.4 percent and a Return on capital employed (ROCE) of 13.5 percent. It has reported a debt-to-equity ratio of 0.40.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by: Bharath K.S<\/strong><\/p><\/blockquote><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also Read<\/strong><\/p>\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-trade-brains wp-block-embed-trade-brains\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"RSt0L14IEA\"><a href=\"https:\/\/tradebrains.in\/features\/stock-jumps-14-after-company-to-acquire-paramount-tpa-for-311-8-cr\/\">Stock jumps 14% after company to acquire Paramount TPA for \u20b9 311.8 Cr\u00a0<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Stock jumps 14% after company to acquire Paramount TPA for \u20b9 311.8 Cr\u00a0&#8221; &#8212; Trade Brains\" src=\"https:\/\/tradebrains.in\/features\/stock-jumps-14-after-company-to-acquire-paramount-tpa-for-311-8-cr\/embed\/#?secret=oxYXu7sRBH#?secret=RSt0L14IEA\" data-secret=\"RSt0L14IEA\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure><\/blockquote><h4 class=\"wp-block-heading has-medium-font-size\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-content-10\" id=\"trade-1996290804\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-3405155225\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Pharma stock engaged in manufacturing and selling APIs, Pharma Intermediates, Specialty Chemicals, and many more jumped 5 percent in the day\u2019s trade following the announcement to Buyback equity shares at a 50 percent premium and fixing record date.&nbsp; Price Action&nbsp; With a market capitalization of Rs. 5,562 Crores, the shares of Aarti Drugs Limited were [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[21942,21943,10171,10170,6616,15654,948,936,2597],"class_list":["post-132029","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-aarti-drugs","tag-aarti-drugs-buy-back","tag-aarti-drugs-latest-news","tag-aarti-drugs-share-price","tag-pharma-stock","tag-pharma-stock-news","tag-stock-market","tag-stock-market-news","tag-stocks-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 5% after company&#039;s board approved buyback at 50% premium - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Pharma stock engaged in manufacturing and selling APIs, Pharma Intermediates, Specialty Chemicals, and many more jumped 5 percent in the day\u2019s trade following the announcement to Buyback equity shares at a 50 percent premium and fixing record date.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 5% after company&#039;s board approved buyback at 50% premium\" \/>\n<meta property=\"og:description\" content=\"Pharma stock engaged in manufacturing and selling APIs, Pharma Intermediates, Specialty Chemicals, and many more jumped 5 percent in the day\u2019s trade following the announcement to Buyback equity shares at a 50 percent premium and fixing record date.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-27T05:51:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-27T05:54:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/\",\"name\":\"Pharma stock jumps 5% after company's board approved buyback at 50% premium - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2024-08-27T05:51:10+00:00\",\"dateModified\":\"2024-08-27T05:54:39+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Pharma stock engaged in manufacturing and selling APIs, Pharma Intermediates, Specialty Chemicals, and many more jumped 5 percent in the day\u2019s trade following the announcement to Buyback equity shares at a 50 percent premium and fixing record date.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 5% after company&#8217;s board approved buyback at 50% premium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 5% after company's board approved buyback at 50% premium - Trade Brains Features","description":"Pharma stock engaged in manufacturing and selling APIs, Pharma Intermediates, Specialty Chemicals, and many more jumped 5 percent in the day\u2019s trade following the announcement to Buyback equity shares at a 50 percent premium and fixing record date.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 5% after company's board approved buyback at 50% premium","og_description":"Pharma stock engaged in manufacturing and selling APIs, Pharma Intermediates, Specialty Chemicals, and many more jumped 5 percent in the day\u2019s trade following the announcement to Buyback equity shares at a 50 percent premium and fixing record date.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-08-27T05:51:10+00:00","article_modified_time":"2024-08-27T05:54:39+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/","name":"Pharma stock jumps 5% after company's board approved buyback at 50% premium - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2024-08-27T05:51:10+00:00","dateModified":"2024-08-27T05:54:39+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Pharma stock engaged in manufacturing and selling APIs, Pharma Intermediates, Specialty Chemicals, and many more jumped 5 percent in the day\u2019s trade following the announcement to Buyback equity shares at a 50 percent premium and fixing record date.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-5-after-companys-board-approved-buyback-at-50-premium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 5% after company&#8217;s board approved buyback at 50% premium"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/132029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=132029"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/132029\/revisions"}],"predecessor-version":[{"id":132033,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/132029\/revisions\/132033"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=132029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=132029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=132029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}